Sherwood, Oregon-based Entia Biosciences, Inc. is a company dedicated to the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. With a focus on the discovery, scientific evaluation, and marketing of natural formulations that can be used in various products including medical foods, nutraceuticals, and cosmetics, the company has created a strong and diverse portfolio of unique formulations. These include ErgoD2, a groundbreaking pharmaceutical grade organic compound from whole food, which contains the essential micro-nutrients; L-Ergothioneine, a naturally occurring amino acid and master antioxidant; and vitamin D, an antioxidant. The company is also involved in the development of products for chronic kidney disease and other illnesses, as well as providing cosmeceuticals and other beauty products under the GROH brand name. Entia Biosciences, Inc distributes its comprehensive range of products directly to consumers via e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. Founded in 2007, the company was formerly known as Total Nutraceutical Solutions, Inc. before it changed its name to Entia Biosciences, Inc. in January 2012.
Ergomed's ticker is ERGO
The company's shares trade on the LSE stock exchange
They are based in Guildford, England
There are 1001-5000 employees working at Ergomed
It is ergomedplc.com
Ergomed is in the Healthcare sector
Ergomed is in the Biotechnology industry
The following five companies are Ergomed's industry peers: